Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Rafael Venson"'
Autor:
Jessica Cristina Balbinot, Astrid Wiens Souza, Roberto Pontarolo, Orli Dutra Boeira Junior, Edson Antonio Alves da Silva, Daniele Schaab Boff Junges, Camila Borges dos Reis, Rafael Venson, Ana Flavia Redolfi Oliota, Andreia Cristina Conegero Sanches
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 58 (2022)
Abstract The objective of this study is to validate the specific questionnaire for Hepatitis B HBQOL (Hepatitis B Quality of Life Instrument, version 1.0) for the Brazilian version, in addition to testing its applicability in patients with hepatitis
Externí odkaz:
https://doaj.org/article/a59097080ae4479bb2f6ddf2a878d2ae
Autor:
Andréia Cristina Conegero Sanches, Cassyano Januário Correr, Rafael Venson, Patrícia Rodrigues Gonçalves, Mariana Martins Garcia, Mário Sérgio Piantavini, Roberto Pontarolo
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 49, Iss 3, Pp 501-509 (2013)
All patients with Diabetes Mellitus (DM) receive insulin therapy. In this study, we evaluated the efficacy, safety and tolerability of human insulin and insulin analogues. We performed a systematic review of the literature and a meta-analysis accordi
Externí odkaz:
https://doaj.org/article/6c516d39026f4b47978ac54b92a7d246
Autor:
Astrid Wiens, Luana Lenzi, Rafael Venson, Maria Lúcia Alves Pedroso, Cassyano Januário Correr, Roberto Pontarolo
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 17, Iss 4, Pp 418-426 (2013)
The aim of this study was to conduct a cost-utility study of adefovir, entecavir, interferon alpha, pegylated interferon alpha, lamivudine and tenofovir for chronic hepatitis B in the context of Brazilian Public Health Care System. A systematic revie
Externí odkaz:
https://doaj.org/article/5cc9c54a8fb6477498bef957a2d03f27
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 48, Iss 4, Pp 781-791 (2012)
The objective is to provide an update on the clinical efficacy, safety and tolerability of the use of abatacept for treating rheumatoid arthritis. A systematic review (up to June 2011) followed by meta-analyses was performed. Randomized controlled cl
Externí odkaz:
https://doaj.org/article/878a360ac0384aaba64c7c6d9a8038b0
Autor:
Astrid Wiens, Mônica Cavichiolo Grochocki, Deise Regina Sprada Pontarolli, Rafael Venson, Cassyano Januário Correr, Roberto Pontarolo
Publikováno v:
Revista Brasileira de Reumatologia, Vol 52, Iss 2, Pp 208-213 (2012)
INTRODUÇÃO: O tratamento da artrite reumatoide (AR) no âmbito do Sistema Único de Saúde (SUS) tem financiamento do Ministério da Saúde e cofinanciamento das Secretarias Estaduais. O Protocolo Clínico e Diretrizes Terapêuticas (PCDT) para o t
Externí odkaz:
https://doaj.org/article/548c0434b91f4cd6ad5763d15d5eab6a
Autor:
Astrid Wiens, M.Sc., Rafael Venson, M.D., Cassyano Januário Correr, M.Sc., Roberto Pontarolo, M.Sc.
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 15, Iss 3, Pp 225-230 (2011)
Background and aim: Chronic hepatitis B is a highly prevalent disease worldwide, leading to serious consequences if not properly treated. Six treatment options for chronic hepatitis B are currently provided by the Brazilian public health system. Telb
Externí odkaz:
https://doaj.org/article/b2c25ff056bf44c7a671aa64836fb4c5
Autor:
Cassyano Januário Correr, Roberto Pontarolo, Rodrigo Augusto de Paula e Souza, Rafael Venson, Ana Carolina Melchiors, Astrid Wiens
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 45, Iss 4, Pp 809-817 (2009)
The aim is to evaluate the humanistic outcomes in type 2 diabetic patients by the adoption of pharmacotherapy follow-up in community pharmacies. Controlled, non-randomized, 12-months trial; n=161 patients distributed into control and intervention gro
Externí odkaz:
https://doaj.org/article/b59c8934b78b4811ac0a1d30fcbcb597
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 15, Iss 3, Pp 225-230
BACKGROUND AND AIM: Chronic hepatitis B is a highly prevalent disease worldwide, leading to serious consequences if not properly treated. Six treatment options for chronic hepatitis B are currently provided by the Brazilian public health system. Telb
Externí odkaz:
https://doaj.org/article/ce9a990b8ac54f80a70c91e08215a0f8
Autor:
Astrid Wiens, Luana Lenzi, Rafael Venson, Maria Lúcia Alves Pedroso, Cassyano Januário Correr, Roberto Pontarolo
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 17, Iss 4, Pp 418-426
The aim of this study was to conduct a cost-utility study of adefovir, entecavir, interferon alpha, pegylated interferon alpha, lamivudine and tenofovir for chronic hepatitis B in the context of Brazilian Public Health Care System. A systematic revie
Externí odkaz:
https://doaj.org/article/52c757609eb44132b989d0e54e80f5bc
Autor:
Layssa Andrade Oliveira, Rosa Camila Lucchetta, Antônio Matoso Mendes, Aline de Fátima Bonetti, Cecilia Silva Xavier, Andréia Cristina Conegero Sanches, Helena Hiemisch Lobo Borba, Ana Flávia Redolfi Oliota, Paula Rossignoli, Patrícia de Carvalho Mastroianni, Rafael Venson, Suzane Virtuoso, Tales Rubens de Nadai, Astrid Wiens
Publikováno v:
Value in Health Regional Issues. 36:34-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ea0fb21a2513f44084432d6b0ca1b5d
https://doi.org/10.1016/j.vhri.2023.02.004
https://doi.org/10.1016/j.vhri.2023.02.004